Wire · operational-macro
Senators Urge FTC to Finalize Pharmacy Benefit Manager Study, Demand Final Report
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 24 October 2026 · Fusion42 review
US Senators Chuck Grassley and Maria Cantwell are pressing the Federal Trade Commission to finalize and publish its delayed 2022 study on pharmacy benefit managers, citing concerns about market concentration, lack of transparency, and high drug prices. They see the final report as crucial to inform potential antitrust legislation and address escalating pharmacy and patient costs.
This Wire brief sits within Fusion42's coverage of Fintech, and 1 source has reported it between 22 Oct 2026 and 26 Oct 2026.
◆ ◆ The Wire takeaway
You face a rising risk as the FTC nears completion of its study that could trigger tighter rules on pharmacy benefit managers. Prepare for regulatory changes that could reshape pricing and contracting if you operate in pharma or insurance.
◆ Coverage
1 source · first reported 22 Oct 2026 · latest 26 Oct 2026
◆ Related on Wire
◆ Topics